Key result
Alda-1 inhibits high glucose-induced proliferation of rat cardiac fibroblasts via Beclin-1 and LC3B upregulation.
Why the study?
It was unclear whether autophagy mediates the effects of aldehyde dehydrogenase 2 (ALDH2) on the proliferation of neonatal rat cardiac fibroblasts cultured in high glucose.
Mitochondrial ALDH2 activation inhibits high glucose-induced proliferation of neonatal rat cardiac fibroblasts, potentially mediated by up-regulation of autophagy-related proteins.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ALDH2-autophagy in high-glucose fibroblast proliferation; in vivo studies needed before any clinical translation.
OBJECTIVE: To investigate whether autophagy mediates the effects of aldehyde dehydrogenase 2 (ALDH2) on the proliferation of neonatal rat cardiac fibroblasts cultured in high glucose. METHODS: Cardiac fibroblasts were isolated from neonatal (within 3 days) SD rats and subcultured. The fibroblasts of the third passage, after identification with immunofluorescence staining for vimentin, were treated with 5.5 mmol/L glucose (control group), 30 mmol/L glucose (high glucose group), or 30 mmol/L glucose in the presence of Alda-1 (an ALDH2 agonist), daidzin (an ALDH2 2 inhibitor), or both. Western blotting was employed to detect ALDH2, microtubule-associated protein 1 light chain 3B subunit (LC3B) and Beclin-1 in the cells, and a hydroxyproline detection kit was used for determining hydroxyproline content in cell culture medium; CCK- 8 kit was used for assessing the proliferation ability of the cardiac fibroblasts after the treatments. RESULTS: Compared with the control cells, the cells exposed to high glucose exhibited obviously decreased expressions of ALDH2, Beclin-1 and LC3B and increased cell number and hydroxyproline content in the culture medium. Treatment of the high glucose-exposed cells with Alda-1 significantly increased Beclin-1, LC3B, and ALDH2 protein expressions and lowered the cell number and intracellular hydroxyproline content, whereas the application of daidzin resulted in reverse changes in the expressions of ALDH2, Beclin-1 and LC3B, viable cell number and intracellular hydroxyproline content in high glucose-exposed cells. CONCLUSIONS: Mitochondrial ALDH2 inhibits the proliferation of neonatal rat cardiac fibroblasts induced by high glucose, and the effect is possibly mediated by the up-regulation of autophagy-related proteins Beclin-1 and LC3B.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2019) studied High glucose-induced proliferation of cardiac fibroblasts. Alda-1 (ALDH2 agonist) and daidzin (ALDH2 inhibitor) vs. High glucose (30 mmol/L) and normal glucose (5.5 mmol/L) controls was evaluated on Cell proliferation, hydroxyproline content, and expression of ALDH2, Beclin-1, and LC3B. Mitochondrial ALDH2 activation with Alda-1 inhibited high glucose-induced proliferation of neonatal rat cardiac fibroblasts, possibly mediated by up-regulation of Beclin-1 and LC3B.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: